Repligen Corp at Jefferies Healthcare Conference (Virtual) Transcript
All right. Good afternoon. Welcome, everybody, to the Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard, I cover the life science tools in diagnostics sector here at the firm. Very happy to have Repligen with us back at the conference this year. Joining us for our conversation this afternoon, Mr. Tony Hunt, CEO; as well as Jon Snodgres, CFO. Thank you both for being here. I will say to anyone in the audience who's listening in, please feel free to e-mail me if you have any questions, and I'll do my best and let's try to work those in.
Questions & Answers
So maybe let's -- if we can just jump right into it, Tony, if think about the bioprocessing industry at a high level, about a $10 billion market, growing sort of high single digits. You've been growing double that rate organically for quite some time, did 33% last year. What are some of the key factors to think about in terms of your ability
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |